Preliminary results from Progenics Pharmaceuticals’ (PGNX -0.5%) Annual Meeting showed that Chairman Peter Crowley and board member Michael Kishbauch failed to receive a majority of votes cast supporting their re-election.
Both have submitted contingent resignations pending the certification of the votes.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.